Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market …PR Newswire UK (press release)The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constitut…
HMHP Program Helps Needy Heart Failure Patients – PR Web (press release)
HMHP Program Helps Needy Heart Failure PatientsPR Web (press release)As many as 39 recently diagnosed heart failure patients who meet specified health and financial-need criteria can participate — free of charge — in a four-month exercise rehabilitat…
BioLineRx Enrolls First Patient in Phase 2 Clinical Trial for BL-8040, for … – Fort Mills Times
BioLineRx Enrolls First Patient in Phase 2 Clinical Trial for BL-8040, for …Fort Mills TimesPre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing bone marrow metastasis of …
Specialist nurses have 'better' knowledge of heart failure guidelines than GPs – Nursing Times
|
Specialist nurses have ‘better’ knowledge of heart failure guidelines than GPs
Nursing Times Professor Martin Cowie, consultant cardiologist at the Royal Brompton Hospital in London, added: “Specialist heart failure nurses have a vital role in helping to implement current best practice, and can be a very important link between primary and … |
Specialist nurses 'more aware' of heart guidance than GPs – Nursing Times
|
Specialist nurses ‘more aware’ of heart guidance than GPs
Nursing Times Awareness of latest European Society of Cardiology heart failure guidance is higher among cardiac nurses and primary care nurses with an interest in cardiology than family doctors, the survey found. Revised guidelines for the diagnosis and treatment of … |
Pfizer Keeping the ADC Faith: Potential $635M CytomX Deal – BioWorld Online
|
Pfizer Keeping the ADC Faith: Potential $635M CytomX Deal
BioWorld Online … antibody-drug conjugate (ADC) composed of a monoclonal antibody targeting CD22, administered in combination with Rituxan (rituximab, Roche AG and Biogen Idec Inc.), in relapsed or refractory CD22-positive aggressive non-Hodgkin’s lymphoma (NHL). |
Dharmendra and sons unleash a fan frenzy in Dubai – gulfnews.com
gulfnews.comDharmendra and sons unleash a fan frenzy in Dubaigulfnews.comDubai: Frenzied fans with incredible lung power are to be expected when Bollywood stars hit a mall in Dubai. … A day before their Dubai trip, the trio had to cancel a mall appea…
Gay rights activist, 18, left brain dead after attack in France – Gay Star News
Gay Star News |
Gay rights activist, 18, left brain dead after attack in France
Gay Star News He now lies in Pitié-Salpêtrière Hospital in Paris in a state of brain death. In a statement, the Parti de Gauche (Left Party) said the ‘horror of fascism has just killed right in the middle of Paris’. Leader Jean-Luc Mélénchon has called on the far … French student, 18, left brain dead after attack by mob of far-right skinheads …Daily Mail French Anti – Fascist Activist Clement Méric Murdered In ParisLez Get Real |
Neuronas obtenidas a partir de células madre de cordón . – El Mundo.es
|
Neuronas obtenidas a partir de células madre de cordón .
El Mundo.es Algunas como los anticuerpos monoclonales, alemtuzumab, daclizumab, o daclizumab, han mostrado en ensayos clínicos mayor eficacia que el interferón beta (la terapia clásica), y otros, en vías de aprobación, como fingolimob y BG12, aportan la ventaja de … |
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies – Xconomy
CytomX Snags $25M From Pfizer to Make Souped-Up AntibodiesXconomyPfizer was tripped up a couple years ago, when safety concerns emerged around the first drug ever approved that could combine the targeting ability of an antibody with a toxin to give it …